RE: New on By health site31 May 2020 18:55
Thanks Bella,
Although the article is a year old it could explain the delay for at least one health claim.
"the review also suggested to relook health claims that require further research evidence. Six claims, which include “aids in lowering of blood pressure” ?and “aids in lowering of blood sugar”?, would be affected."
"Regulatory advice ?
Regulatory experts have advised manufacturers to halt the R&D of products that bear claims which may require additional scientific research. This was because these claims might not be approved eventually, thus, if manufacturers were to proceed with R&D of these products, their past efforts would go down the drain, Charles Diao, regulatory manager at US-China Health Products Association told NutraIngredients-Asia."
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020077747&_cid=P10-K9F8JJ-45635-1